Edition:
United States

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

2.38USD
10:35am EDT
Change (% chg)

$0.01 (+0.63%)
Prev Close
$2.37
Open
$2.36
Day's High
$2.39
Day's Low
$2.35
Volume
43,476
Avg. Vol
413,501
52-wk High
$5.01
52-wk Low
$2.20

Select another date:

Fri, Jun 16 2017

BRIEF-Celldex Therapeutics promotes Sam Martin as CFO

* Celldex Therapeutics announces additions to the board of directors and senior management team

BRIEF-Celldex presents data from phase 2 study of glembatumumab vedotin

* Celldex presents promising overall survival data from phase 2 study of single-agent glembatumumab vedotin in patients with checkpoint-refractory metastatic melanoma

BRIEF-Celldex reports Q1 loss per share $0.28

* Q1 earnings per share view $-0.29 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-COLUMBIA WANGER ASSET MANAGEMENT LLC REPORTS 5.1 PCT PASSIVE STAKE IN CELLDEX THERAPEUTICS AS OF DEC 31, 2016

* COLUMBIA WANGER ASSET MANAGEMENT LLC REPORTS A 5.1 PERCENT PASSIVE STAKE IN CELLDEX THERAPEUTICS INC AS OF DEC 31, 2016 - SEC FILING Source text (http://bit.ly/2lwtvZF) Further company coverage:

BRIEF-Celldex Therapeutics files for offering of up to 18.4 mln shares of common stock

* Files for offering of up to 18.4 million shares of common stock by the selling stockholders Source text : (http://bit.ly/2kpoaTY) Further company coverage:

Select another date: